6-(thiophen-3-yl)pyridin-2-amine 、 异硫氰酰甲酸乙酯 在
c-Hex 作用下,
以
1,4-二氧六环 为溶剂,
反应 16.0h,
以to give the title compound as a white solid (4.73 g; 73%)的产率得到ethyl ({[6-(3-thienyl)pyridin-2-yl]amino}carbonothioyl)carbamate
参考文献:
名称:
Triazolopyridine compounds and their use as ask inhibitors
The Highly Efficient Suzuki-Miyaura Cross-Coupling of (Hetero)aryl Chlorides and (Hetero)arylboronic Acids Catalyzed by “Bulky-yet-Flexible” Palladium-PEPPSI Complexes in Air
作者:Jia-Sheng Ouyang、Yan-Fang Li、Fei-Dong Huang、Dong-Dong Lu、Feng-Shou Liu
DOI:10.1002/cctc.201701076
日期:2018.1.23
Pd–PEPPSI complexes were designed and synthesized. The relationship between catalyst structure and properties was systematically investigated. It was revealed that “bulky‐yet‐flexible” C3 bearing ancenaphthyl backbone was a highlyefficient precatalyst and could be successfully employed in Suzuki–Miyaura reactions of (hetero)arylchlorides with (hetero)arylboronic acids at a low palladium loading in the presence
[EN] TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE AS ASK INHIBITORS<br/>[FR] COMPOSÉS DE TRIAZOLOPYRIDINE ET LEUR UTILISATION COMME INHIBITEURS DE ASK
申请人:SERONO LAB
公开号:WO2009027283A1
公开(公告)日:2009-03-05
The present invention relates to triazolopyridine compounds according to Formula (I), their use as medicament, for treating autoimmune disorders, inflammatorydiseases, cardiovascular disceases and/or neurodegenerative diseases and a process for their preparation.
Triazolopyridine Compounds and Their Use as Ask Inhibitors
申请人:Swinnen Dominique
公开号:US20100197681A1
公开(公告)日:2010-08-05
The present invention relates to triazolopyridine compounds according to Formula (I), their use as medicament, for treating autoimmune disorders, inflammatory diseases, cardiovascular diseases and/or neurodegenerative diseases and a process for their preparation.
Triazolopyridine compounds and their use as ask inhibitors
申请人:Merck Serono SA
公开号:US08263595B2
公开(公告)日:2012-09-11
The present invention relates to triazolopyridine compounds according to Formula (I), their use as medicament, for treating autoimmune disorders, inflammatory diseases, cardiovascular diseases and/or neurodegenerative diseases and a process for their preparation.